Market Exclusive

Adverum Biotechnologies Inc (NASDAQ:ADVM) price target raised to $8.00 by Cantor Fitzgerald

Analyst Ratings For Adverum Biotechnologies Inc (NASDAQ:ADVM)

Today, Cantor Fitzgerald raised its price target on Adverum Biotechnologies Inc (NASDAQ:ADVM) to $8.00 per share.

There are 4 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Adverum Biotechnologies Inc (NASDAQ:ADVM) is Hold with a consensus target price of $8.50 per share, a potential 35.57% upside.

Some recent analyst ratings include

Recent Trading Activity for Adverum Biotechnologies Inc (NASDAQ:ADVM)
Shares of Adverum Biotechnologies Inc closed the previous trading session at 6.16 −0.13 2.15% with 5.89 shares trading hands.

Exit mobile version